Science Explorer Back to mapMap
Discussion
Institution · Centrum Medyczne iMed24

Most cited papers from Centrum Medyczne iMed24

Centrum Medyczne iMed24

What are the most cited papers from Centrum Medyczne iMed24?

The most cited paper from Centrum Medyczne iMed24 is "Ferric Carboxymaltose in Patients with Heart Failure and Iron Deficiency" (Stefan D. Anker, Josep Comín Colet, Gerasimos S Filippatos et al., 2009), with 2,090 citations. Next come "Implementing TIMERS: the race against hard-to-heal wounds" (371) and "Efficacy and Safety of Baricitinib Combined With Topical Corticosteroids for Treatment of Moderate to Severe Atopic Dermatitis" (284).

Showing 50 of 60 papers. Every paper with more than 9 citations is listed.

Most cited papers, sortable by citations and release date
#Paper
1 Ferric Carboxymaltose in Patients with Heart Failure and Iron Deficiency Stefan D. Anker, Josep Comín Colet, Gerasimos S Filippatos et al. · New England Journal of Medicine Open access 17 Nov 2009 2,090
2 Implementing TIMERS: the race against hard-to-heal wounds Leanne Atkin, Zofia Bućko, Elena Conde Montero et al. · Journal of Wound Care Open access Mar 2019 371
3 Efficacy and Safety of Baricitinib Combined With Topical Corticosteroids for Treatment of Moderate to Severe Atopic Dermatitis Kristian Reich, Kenji Kabashima, Ketty Peris et al. · JAMA Dermatology Open access 30 Sep 2020 284
4 The incidence and clinical analysis of non-melanoma skin cancer Magdalena A. Ciążyńska et al. · Scientific Reports Open access 22 Feb 2021 272
5 Alterations of the Skin and Gut Microbiome in Psoriasis and Psoriatic Arthritis Irmina Olejniczak‐Staruch, Magdalena A. Ciążyńska, Dorota Sobolewska-Sztychny et al. · International Journal of Molecular Sciences Open access 13 Apr 2021 214
6 Efficacy and safety of filgotinib, a selective Janus kinase 1 inhibitor, in patients with active psoriatic arthritis (EQUATOR): results from a randomised, placebo-controlled, phase 2 trial Philip J. Mease, Laura C. Coates, Philip Helliwell et al. · The Lancet Open access 22 Oct 2018 207
7 Strontium Ranelate Reduces the Risk of Vertebral and Nonvertebral Fractures in Women Eighty Years of Age and Older Ego Seeman, Bruno J. Vellas, Claude Laurent Benhamou et al. · Journal of Bone and Mineral Research Jul 2006 200
8 Management of epithelial precancerous conditions and early neoplasia of the stomach (MAPS III): European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter and Microbiota Study Group (EHMSG) and European Society of Pathology (ESP) Guideline update 2025 Mário Jorge Dinis-Ribeiro et al. · Endoscopy Open access 20 Mar 2025 178
9 MOR103, a human monoclonal antibody to granulocyte–macrophage colony-stimulating factor, in the treatment of patients with moderate rheumatoid arthritis: results of a phase Ib/IIa randomised, double-blind, placebo-controlled, dose-escalation trial Frank Behrens, Paul Peter Tak, Mikkel Østergaard et al. · Annals of the Rheumatic Diseases Open access 18 Feb 2014 151
10 Cerebral Oximetry Monitoring in Extremely Preterm Infants Mathias Lühr Hansen et al. · New England Journal of Medicine Open access110 authors 19 Apr 2023 105
11 Safety and efficacy of nipocalimab in adults with generalised myasthenia gravis (Vivacity-MG3): a phase 3, randomised, double-blind, placebo-controlled study Carlo Giuseppe Antozzi et al. · The Lancet Neurology 22 Jan 2025 99
12 Effect of Stopping Risedronate after Long-Term Treatment on Bone Turnover Richard Eastell, R.A. Hannon, Dietrich Wenderoth et al. · The Journal of Clinical Endocrinology & Metabolism Open access 24 Aug 2011 87
13 Efficacy and Safety of Biosimilar FYB201 Compared with Ranibizumab in Neovascular Age-Related Macular Degeneration Frank Gerhard Holz, Piotr Oleksy, Federico Ricci et al. · Ophthalmology Open access 3 May 2021 70
14 Obesity and the Risk of Gastrointestinal Cancers Jacek Karczewski, Beata Krasińska, Rafał Staszewski et al. · Digestive Diseases and Sciences Open access 9 Apr 2019 67
15 Imsidolimab, an anti-interleukin-36 receptor monoclonal antibody, for the treatment of generalized pustular psoriasis: results from the phase II GALLOP trial Richard Bruce Warren, Adam Reich, Andrzej Kaszuba et al. · British Journal of Dermatology Open access 30 Apr 2023 57
16 A Partly Fermented Infant Formula with Postbiotics Including 3′-GL, Specific Oligosaccharides, 2′-FL, and Milk Fat Supports Adequate Growth, Is Safe and Well-Tolerated in Healthy Term Infants: A Double-Blind, Randomised, Controlled, Multi-Country Trial Yvan Vandenplas, Virginie de Halleux, Małgorzata Arciszewska et al. · Nutrients Open access 20 Nov 2020 56
17 Effects of an Extensively Hydrolyzed Formula Supplemented with Two Human Milk Oligosaccharides on Growth, Tolerability, Safety and Infection Risk in Infants with Cow’s Milk Protein Allergy: A Randomized, Multi-Center Trial Yvan Vandenplas, Marta Żołnowska, Roberto Berni Canani et al. · Nutrients Open access 26 Jan 2022 54
18 Cobitolimod for moderate-to-severe, left-sided ulcerative colitis (CONDUCT): a phase 2b randomised, double-blind, placebo-controlled, dose-ranging induction trial Raja Narayana Atreya, Laurent Peyrin‐Biroulet, A. V. Klymenko et al. · ˜The œLancet. Gastroenterology & hepatology 5 Oct 2020 51
19 Andecaliximab [Anti-matrix Metalloproteinase-9] Induction Therapy for Ulcerative Colitis: A Randomised, Double-Blind, Placebo-Controlled, Phase 2/3 Study in Patients With Moderate to Severe Disease William J. Sandborn, Bal Raj Bhandari, Charles W. Randall et al. · Journal of Crohn s and Colitis Open access 13 May 2018 50
20 Efficacy and Safety of Lenabasum, a Cannabinoid Type 2 Receptor Agonist, in a Phase 3 Randomized Trial in Diffuse Cutaneous Systemic Sclerosis Robert Spiera et al. · Arthritis & Rheumatology Open access 26 Apr 2023 44
21 Specificity of cytochemical and fluorescence methods of senescence-associated β-galactosidase detection for ageing driven by replication and time Patrycja Sosińska, Justyna Mikuła‐Pietrasik, Monika Ryżek et al. · Biogerontology Open access 30 May 2014 44
22 Clinical and epidemiological analysis of basosquamous carcinoma: results of the multicenter study Magdalena A. Ciążyńska et al. · Scientific Reports Open access 28 Oct 2020 43
23 Evaluation of LL ‐37 in healing of hard‐to‐heal venous leg ulcers: A multicentric prospective randomized placebo‐controlled clinical trial Margit Mahlapuu, Adam Sidorowicz, Jacek Mikosiński et al. · Wound Repair and Regeneration Open access 23 Oct 2021 41
24 Application of holography and augmented reality based technology to visualize the internal structure of the dental root – a proof of concept Damian Dołęga‐Dołegowski, Klaudia K. Proniewska, Magdalena Dolega-Dolegowska et al. · Head & Face Medicine Open access 5 Apr 2022 40
25 Chronic wounds multimodal image database Michał Kręcichwost, Joanna Czajkowska, Agata M. Wijata et al. · Computerized Medical Imaging and Graphics Open access 8 Jan 2021 38
26 Efficacy, Safety and Immunogenicity of AVT02 Versus Originator Adalimumab in Subjects with Moderate to Severe Chronic Plaque Psoriasis: A Multicentre, Double-Blind, Randomised, Parallel Group, Active Control, Phase III Study Steven R. Feldman, Nataliya Reznichenko, Grażyna Pulka et al. · BioDrugs Open access 16 Oct 2021 32
27 Efficacy and safety of biosimilar CT-P17 versus reference adalimumab in subjects with rheumatoid arthritis: 24-week results from a randomized study Jonathan Kay, Janusz Jaworski, Rafał Wojciechowski et al. · Arthritis Research & Therapy Open access 5 Feb 2021 32
28 CT ‐ P39 Compared With Reference Omalizumab in Chronic Spontaneous Urticaria: Results From a Double‐Blind, Randomized, Active‐Controlled, Phase 3 Study Sarbjit S. Saini, Marcus Maurer, Yevgeniya Dytyatkovska et al. · Allergy Open access 9 Jan 2025 31
29 Arthroscopic acetabular labral reconstruction with rectus femoris tendon autograft: Our experiences and early results Ritesh A. Rathi, Jacek Mazek · Journal of Orthopaedics Open access 20 Jun 2018 31
30 Efficacy and Safety of Candidate Biosimilar CT-P43 Versus Originator Ustekinumab in Moderate to Severe Plaque Psoriasis: 28-Week Results of a Randomised, Active-Controlled, Double-Blind, Phase III Study Kim Alexander Papp et al. · BioDrugs Open access 22 Nov 2023 30
31 Health-Related Quality of Life With Adjuvant Docetaxel- and Trastuzumab-Based Regimens in Patients with Node-Positive and High-Risk Node-Negative, HER2-Positive Early Breast Cancer: Results from the BCIRG 006 Study Heather‐Jane Au, Wolfgang EIERMANN, Nicholas J. Robert et al. · The Oncologist Open access 28 Jun 2013 28
32 Effectiveness of Laser-Assisted Teeth Bleaching: A Systematic Review Jan Kiryk, Sylwia Kiryk, Julia Kensy et al. · Applied Sciences ReviewOpen access 11 Oct 2024 24
33 Baseline new bone formation does not predict bone loss in ankylosing spondylitis as assessed by quantitative computed tomography (QCT) - 10-year follow-up Mariusz Korkosz, Jerzy Gąsowski, Piotr Grzanka et al. · BMC Musculoskeletal Disorders Open access 31 May 2011 23
34 Factors affecting the quality of life in hemifacial spasm patients Monika Rudzińska, Magdalena Wójcik-Pędziwiatr, Michalina Malec et al. · Neurologia i Neurochirurgia Polska Open access 2012 23
35 Performance measures for upper gastrointestinal endoscopy: a European Society of Gastrointestinal Endoscopy (ESGE) Quality Improvement Initiative – Update 2025 Miguel Areia, Gianluca Esposito, Philippe Leclercq et al. · Endoscopy Open access 11 Sep 2025 22
36 Extremely Preterm Infant Admissions Within the SafeBoosC-III Consortium During the COVID-19 Lockdown Marie Isabel Rasmussen et al. · Frontiers in Pediatrics Open access 12 Jul 2021 22
37 Knowledge and Awareness of Colorectal Cancer Miłosz Lewandowski, Przemysław Lipiński, Igor Aleksander Bednarski et al. · Polish Journal of Surgery 11 Feb 2020 22
38 Cytomegalovirus Infection in Pregnancy Prevention and Treatment Options: A Systematic Review and Meta-Analysis Magda Rybak-Krzyszkowska, Joanna Natalia Gorecka, Hubert K. Huras et al. · Viruses ReviewOpen access 24 Oct 2023 21
39 Efficacy and safety of switching from reference adalimumab to CT-P17 (100 mg/ml): 52-week randomized, double-blind study in rheumatoid arthritis Daniel E. Furst, Janusz Jaworski, Rafał Wojciechowski et al. · Lara D. Veeken Open access 21 May 2021 21
40 Safety and Tolerance of a Novel Anti‐Regurgitation Formula Marc M. Bellaiche, Thomas G. Ludwig, Małgorzata Arciszewska et al. · Journal of Pediatric Gastroenterology and Nutrition Open access 19 Aug 2021 20
41 The prospective validation of a scoring system to assess mucosal cleanliness during EGD Marcin Romańczyk, Bartosz Ostrowski, Magdalena Lesińska et al. · Gastrointestinal Endoscopy 11 Jan 2024 19
42 Long‐acting implantable corticosteroid matrix for chronic rhinosinusitis: Results of LANTERN Phase 2 randomized controlled study Anders Cervin, Joanne Rimmer, Agnieszka Wróbel et al. · International Forum of Allergy & Rhinology Open access 17 Sep 2021 18
43 Aflibercept Biosimilar MYL-1701P vs Reference Aflibercept in Diabetic Macular Edema Susan B. Bressler et al. · JAMA Ophthalmology Open access134 authors 12 Sep 2024 17
44 Efficacy and safety of candidate biosimilar CT-P41 versus reference denosumab: a double-blind, randomized, active-controlled, Phase 3 trial in postmenopausal women with osteoporosis Jean‐Yves Reginster, Edward J. Czerwinski, Krzysztof Wilk et al. · Osteoporosis International Open access 23 Jul 2024 17
45 Roxadustat versus placebo for patients with lower‐risk myelodysplastic syndrome: MATTERHORN phase 3, double‐blind, randomized controlled trial Moshe Mittelman, David H. Henry, John A. Glaspy et al. · American Journal of Hematology Open access 17 Jun 2024 17
46 Usability of Prefilled Syringe and Autoinjector for SB4 (An Etanercept Biosimilar) in Patients with Rheumatoid Arthritis Young Hee Rho, Anna Rychlewska-Hańczewska, Beata Śliwowska et al. · Advances in Therapy Aug 2019 17
47 A phase 2 trial investigating the efficacy and safety of the mPGES-1 inhibitor vipoglanstat in systemic sclerosis-related Raynaud's Göran Tornling, Charlotte Edenius, John David Pauling et al. · Lara D. Veeken Open access 30 Jan 2024 16
48 Wound 3D Geometrical Feature Estimation Using Poisson Reconstruction Jan Juszczyk, Agata M. Wijata, Joanna Czajkowska et al. · IEEE Access Open access 30 Oct 2020 14
49 Retinal Displacement Following Vitrectomy for Rhegmatogenous Retinal Detachment: A Systematic Review of Surgical Techniques, Tamponade Agents, and Outcomes Paulina Siwik, Tomasz Chudoba, Sławomir Cisiecki · Journal of Clinical Medicine ReviewOpen access 3 Jan 2025 13
50 Ultrasonographic Signs of Cytomegalovirus Infection in the Fetus—A Systematic Review of the Literature Magda Rybak-Krzyszkowska, Joanna Natalia Gorecka, Hubert K. Huras et al. · Diagnostics ReviewOpen access 18 Jul 2023 13

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.